S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
The Latest: California urges halt to 300K vaccine doses
Canada urges Biden not to cancel oil pipeline on first day
pixel
Alberta leader urges Biden to hear case for Keystone XL
Biden picks Chopra, Gensler for financial oversight roles
The Latest: Swiss quarantine 2 hotels over new virus variant
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
The Latest: California urges halt to 300K vaccine doses
Canada urges Biden not to cancel oil pipeline on first day
pixel
Alberta leader urges Biden to hear case for Keystone XL
Biden picks Chopra, Gensler for financial oversight roles
The Latest: Swiss quarantine 2 hotels over new virus variant
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
The Latest: California urges halt to 300K vaccine doses
Canada urges Biden not to cancel oil pipeline on first day
pixel
Alberta leader urges Biden to hear case for Keystone XL
Biden picks Chopra, Gensler for financial oversight roles
The Latest: Swiss quarantine 2 hotels over new virus variant
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
The Latest: Some Polish hospitals suspend vaccination
pixel
Carmaker Stellantis shares jump in Milan, Paris on first day
The Latest: California urges halt to 300K vaccine doses
Canada urges Biden not to cancel oil pipeline on first day
pixel
Alberta leader urges Biden to hear case for Keystone XL
Biden picks Chopra, Gensler for financial oversight roles
The Latest: Swiss quarantine 2 hotels over new virus variant
pixel
Log in
NASDAQ:FGEN

FibroGen Earnings Date, Estimates & History

$43.23
+0.17 (+0.39 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$41.45
Now: $43.23▼
$44.36
50-Day Range
$37.09
MA: $40.33▼
$44.24
52-Week Range
$22.65
Now: $43.23▼
$51.56
Volume78,470 shs
Average Volume718,130 shs
Market Capitalization$3.93 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.59

Earnings

FibroGen (NASDAQ:FGEN) Earnings Information

FibroGen last posted its quarterly earnings data on November 5th, 2020. The biopharmaceutical company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of ($0.80) by $1.15. The company had revenue of $44.03 million for the quarter, compared to analysts' expectations of $61.49 million. Its quarterly revenue was up 32.7% on a year-over-year basis. FibroGen has generated ($0.89) earnings per share over the last year. FibroGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 1st, 2021 based off prior year's report dates.

FibroGen Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FibroGen (NASDAQ:FGEN) Earnings Estimates

2021 EPS Consensus Estimate: ($0.83)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20214($0.84)$0.46($0.02)
Q2 20213($0.74)$0.43($0.31)
Q3 20213($0.30)$0.65$0.04
Q4 20212($0.54)($0.54)($0.54)
Q1 20221($0.67)($0.67)($0.67)
Q2 20221($0.59)($0.59)($0.59)
Q3 20221($0.47)($0.47)($0.47)

FibroGen (NASDAQ FGEN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/1/2021
(Estimated)		       
11/5/20209/30/2020($0.80)$0.35$0.35$61.49 million$44.03 millionListen
8/6/20206/30/2020($0.64)($0.95)($0.95)$48.29 million$42.90 millionTranscript
5/7/20203/31/2020($0.39)($0.89)($0.89)$72.58 million$24.40 millionTranscript
3/2/2020Q4 2019($0.59)($1.12)($1.12)$40.32 million$7.97 millionTranscript
11/11/20199/30/2019($0.59)($0.57)($0.57)$31.61 million$33.17 millionTranscript
8/8/2019Q2 2019($0.49)$1.26$1.26$29.03 million$191.57 millionTranscript
5/9/2019Q1($0.68)($0.53)($0.53)$20.44 million$23.90 millionListen
2/27/2019Q4 2018$0.02$0.23$0.23$72.15 million$108.05 millionTranscript
11/8/20189/30/2018($0.35)($0.50)($0.50)$36.48 million$29.00 millionListen
8/7/2018Q2 2018($0.59)($0.28)($0.28)$28.70 million$43.95 millionN/A
5/9/2018Q1 2018($0.51)($0.50)($0.50)$29.07 million$31.90 millionN/A
2/27/2018Q4 2017($0.28)($0.27)($0.27)$45.37 million$42.51 millionN/A
11/8/2017Q3 2017($0.37)($0.50)($0.50)$41.34 million$27.27 millionN/A
8/7/2017Q2 2017($0.47)($0.48)($0.48)$34.80 million$29.00 millionListen
5/9/2017Q1 2017($0.63)($0.52)($0.52)$26.02 million$26.89 millionListen
3/1/2017Q4 2016($0.53)($0.54)($0.54)$19.29 million$31.91 millionListen
11/8/2016Q3($0.63)($0.38)($0.38)$24.30 million$30.10 millionListen
8/8/2016Q2$0.36$0.35$0.35$80.58 million$89.28 millionListen
5/9/2016Q116($0.56)($0.45)($0.45)$16.89 million$28.28 millionListen
2/29/2016Q4($0.54)($0.85)($0.85)$40.44 million$24.44 millionListen
11/12/2015Q3($0.6050)($0.74)($0.74)$28.74 million$19.54 millionListen
8/13/2015Q215$0.73$0.83$0.83$111.75 million$120.55 millionListen
5/12/2015Q115($0.53)($0.78)($0.78)$34.00 million$16.30 millionN/A
3/26/2015Q414($0.90)($0.82)$16.49 million$16.11 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/19/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.